4.8 Article

Photothermally triggered on-demand insulin release from reduced graphene oxide modified hydrogels

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 246, Issue -, Pages 164-173

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.10.028

Keywords

Hydrogel; Reduced graphene oxide; Insulin; Photothermal; Release

Funding

  1. Centre National de la Recherche Scientifique (CNRS)
  2. University Lille1
  3. CPER Photonics for Society
  4. Nord Pas de Calais Region
  5. Institut Universitaire de France (IUF)
  6. European Union [690836]
  7. Marie Curie Actions (MSCA) [690836] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

On-demand delivery of therapeutics plays an essential role in simplifying and improving patient care. The high loading capacity of reduced graphene oxide (rGO) for drugs has made this matrix of particular interest for its hybridization with therapeutics. In this work, we describe the formulation of rGO impregnated poly(ethylene glycol) dimethacrylate based hydrogels (PEGDMA-rGO) and their efficient loading with insulin. Near-infrared (NIR) light induced heating of the PEGDMA-rGO hydrogels allows for highly efficient insulin release. Most importantly, we validate that the NIR irradiation of the hydrogel has no effect on the biological and metabolic activities of the released insulin. The ease of insulin loading/reloading makes this photothermally triggered release strategy of interest for diabetic patients. Additionally, the rGO-based protein releasing platform fabricated here can be expanded towards 'on demand' release of various other therapeutically relevant biomolecules. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available